Acute Myeloid Leukemia (AML): Diagnosis Rates, Facts & Statistics (2024)

Approximately 20,000 people are diagnosed with Acute Myeloid Leukemia (AML) each year in the United States. AML is an aggressive blood cancer originating in the bone marrow, where it disrupts normal blood cell production.

Key Facts

• Most common acute leukemia in adults (typically diagnosed around age 68).
• Second most common leukemia in children (after acute lymphoblastic leukemia).
• Lifetime risk: ~0.5% (1 in 200) for men and women.
• 5-year relative survival rate: ~30% overall, but varies significantly by age, genetic subtype, and treatment response.

Risk Factors

• Prior chemotherapy/radiation therapy
• Exposure to benzene, formaldehyde
• Smoking
• Certain genetic disorders (Down syndrome, Fanconi anemia)
• Pre-existing blood disorders (myelodysplastic syndromes)

Early symptoms often mimic flu or fatigue: fever, infections, easy bruising, shortness of breath. Diagnosis requires blood tests and bone marrow biopsy. Treatment typically involves intensive chemotherapy, targeted therapy, and sometimes stem cell transplant.